The Innovative Medicines Initiative (IMI) warmly encourages small and medium-sized enterprises, patient organisations, regulatory authorities, academic teams, industry, hospitals and other organisations with an interest in IMI projects to take part in the IMI Open Info Day.
Attendees will have the opportunity to directly interact with the coordinators of the topics of IMI's 4th Call for proposals, which will be launched soon. The Open Info Day will feature workshops on the different Call topics, as well as more general presentations on how to apply for IMI funding. There will be extensive networking opportunities with IMI staff and representatives of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
For more information on the event, please visit:
http://www.imi.europa.eu
http://www.imi.europa.eu
About Innovative Medicines Initiative (IMI)
The Innovative Medicines Initiative (IMI) is Europe's largest public-private partnership aiming to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients.
The Innovative Medicines Initiative (IMI) is Europe's largest public-private partnership aiming to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients.
With a €2 billion euro budget, IMI supports collaborative research projects and builds networks of industrial and academic experts in Europe that will boost innovation in healthcare. Acting as a neutral third party in creating innovative partnerships, IMI aims to build a more collaborative ecosystem for pharmaceutical research and development (R&D). IMI will provide socio-economic benefits to European citizens, increase Europe's competitiveness globally and establish Europe as the most attractive place for pharmaceutical R&D.
0 comments:
Post a Comment